The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to begin learning the link between Marksans Pharma Limited ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. We ...

Economic uncertainty and market volatility have shown once again why it's vital to have high quality stocks in your portfolio. Safe, profitable companies with strong balance sheets can offer solid ...

BOCA RATON, Fla., Oct. 12, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Marksans Pharma, Ltd to market its Abbreviated New Drug ...

In the months since the FDA identified a probable carcinogen in tested lots of generic diabetes med metformin, the list of companies pulling their versions off U.S. shelves has continued to grow. Now, ...

Massachusetts Institute of Technology acquired 66 lakh shares of the pharma at an average price of Rs 158 apiece, as per the bulk deal data on the National Stock Exchange (NSE). This took the deal ...

The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.

Seamless reading experience. Save your favourite. The reason for recall is " various strengths of Ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies," ...

Marksans Pharma Q1 Results Live : Marksans Pharma Q1 Results Live : Marksans Pharma declared their Q1 results on 13 Aug, 2024. The topline increased by 18.12% & the profit increased by 29.27% YoY. As ...

Shares of Marksans Pharma surged over 12 per cent, bucking the negative market trend, after the pharma company received approval from the US health regulator for loratadine liquid filled capsules, ...

Marksans Pharma in a filing to exchanges said the company will acquire Teva Pharma’s business relating to the manufacture and supply of bulk pharmaceutical formulations in Plot No. Al, Phase l-A, ...

Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa. Marksans Pharma shares surged as much as 12.5 per cent to hit ...